(Q77950481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

D Popovic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

K M El-Shami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

E Vadai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Feldman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

E Tzehoval

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

623-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932609%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006508413070

9 December 2019

exact match

0 references

cites work

Cloning and expression of murine IL-12

1 reference

12 December 2020

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

12 December 2020

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

12 December 2020

Biology of human TH1 and TH2 cells

1 reference

12 December 2020

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases

1 reference

12 December 2020

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

12 December 2020

Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts

1 reference

12 December 2020

Interleukin 12: a new clinical player in cytokine therapy

1 reference

12 December 2020

Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.

1 reference

12 December 2020

Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.

1 reference

12 December 2020

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

1 reference

12 December 2020

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

12 December 2020

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

1 reference

12 December 2020

Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones

1 reference

12 December 2020

Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo

1 reference

12 December 2020

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Interleukin-12 and its role in the generation of TH1 cells

1 reference

12 December 2020

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

12 December 2020

Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells

1 reference

12 December 2020

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells

1 reference

12 December 2020

Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

1 reference

12 December 2020

Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12

1 reference

12 December 2020

Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo

1 reference

12 December 2020

Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis

1 reference

12 December 2020

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

1 reference

12 December 2020

Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.

1 reference

12 December 2020

IL-12: a key cytokine in immune regulation

1 reference

12 December 2020

In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen

1 reference

12 December 2020

Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12

1 reference

12 December 2020

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

1 reference

12 December 2020